US FDA Accepts New Drug Application for Treatment of Rare Lung Condition
Submitted by lsekela on September 26, 2017 - 09:27 AM
The inhaled ciprofloxacin formulations are product candidates for the prevention and treatment of high threat and bioterrorism infections.
Content Source:
Rare Disease Report
Content Author:
Mathew Shanley, Jim Radke
Tags: